SynthesisCurrent gastroenterology reports2026
Switching from Intravenous to Subcutaneous Infliximab in Children with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
Elizabeth A SpencerPubMed ↗Publisher ↗
No numbers read from the abstract.